News & Events

The coronavirus challenges people around the world every day. Here at the MDC, we are giving our best to help fight the pandemic. Some of our scientists took the time to think about a few of the questions surrounding SARS-CoV-2.

It’s been a bit of a mystery: is a particular family of proteins responsible for cell survival or cell death in the intestinal lining? A new mouse model developed at the Max Delbrück Centre for Molecular Medicine (MDC) provides clear evidence and a potential treatment target for inflammatory bowel disease.

Anton Henssen works as a paediatrician and researches rare tumours at the Max Delbrück Center. Incidentally, he’s also a conceptual artist with way more to his paintings than meets the eye.

We'd like to introduce a new series of "What are you reading?" of book recommendations by MDC scientists and staff members. Professor Udo Heinemann is a structural biologist for researches gene regulation & RNA biology. He is also the MDC's Ombudsperson for good scientific practice.

Together with Charité and WIS, the MDC is establishing the German-Israeli Helmholtz International Research School iNAMES – an interdisciplinary training program for PhD students interested in imaging.

A chlamydia infection triggers an inflammatory response at the cellular level. MDC researchers conducted experiments in cell cultures to examine the role that the enzyme GBP1 plays in this response. They have now published their findings in Cell Reports.

Three minutes – that’s all the time FameLab contestants have to present their research in a dynamic and engaging way. On May 14, 2020, Ian Stewart, a scientist in James Poulet’s lab at the Max Delbrück Center for Molecular Medicine (MDC), will be taking part in the competition’s national final.

LabHive is one of 1,500 projects born out of the federal government’s #WirVsVirus hackathon. Team leader Dr. Tobias Opialla of the MDC presents the new online platform, which is intended to bundle laboratory capacity and enable more SARS-CoV-2 tests.